Incorporating ulipristal acetate in the care of symptomatic uterine fibroids: a Canadian cost-utility analysis of pharmacotherapy management.
about
Ulipristal acetate for pre-operative treatment of moderate-to-severe uterine fibroids in women of reproductive age in The Netherlands: cost minimization analysis and budget impact analysis.Selective progesterone receptor modulators for fertility preservation in women with symptomatic uterine fibroids.
P2860
Incorporating ulipristal acetate in the care of symptomatic uterine fibroids: a Canadian cost-utility analysis of pharmacotherapy management.
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Incorporating ulipristal aceta ...... of pharmacotherapy management.
@ast
Incorporating ulipristal aceta ...... of pharmacotherapy management.
@en
type
label
Incorporating ulipristal aceta ...... of pharmacotherapy management.
@ast
Incorporating ulipristal aceta ...... of pharmacotherapy management.
@en
prefLabel
Incorporating ulipristal aceta ...... of pharmacotherapy management.
@ast
Incorporating ulipristal aceta ...... of pharmacotherapy management.
@en
P2093
P2860
P356
P1476
Incorporating ulipristal aceta ...... of pharmacotherapy management
@en
P2093
Bernice Tsoi
Clare J Reade
Gord Blackhouse
Ron Goeree
Simon Ferrazzi
P2860
P304
P356
10.2147/CEOR.S78115
P407
P50
P577
2015-04-17T00:00:00Z